William M. Merritt

William M. Merritt

Oncology

166 Stoneridge Drive
Columbia, SC 29210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Author Correction: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.

Journal: Nature medicine

Published: November 20, 2021

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy.

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 17, 2019

Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.

Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.

Journal: Molecular cancer therapeutics

Published: August 13, 2014

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute.

Journal: Cancer medicine

Published: May 27, 2014

A novel platform for detection of CK+ and CK- CTCs.

A novel platform for detection of CK+ and CK- CTCs.

Journal: Cancer discovery

Published: December 20, 2011

Showing 1-5 of 5

Last Updated: 09/26/2026